Tectonic Therapeutic | AVRO - Lucro Bruto Sobre Vendas

Preço das Ações
31.61
Mudança Diária
-0.54 -1.68%
Mensal
47.92%
Anual
42.52%
Q1 Previsão
32.30




Lucro Bruto Sobre Vendas Alterar Data
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Cspc Pharmaceutical CNY 4.34B 333.68M 2025-09
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
MacroGenics USD 31.11M 30.14M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 31.84M 23.88M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Pharma Mar EUR 86.7M 53.34M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Sartorius EUR 393.2M 23M 2025-09
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Takeda JPY 790.55B 262.97B 2025-12
Tilray USD 67.63M 15.62M 2025-03
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06